Description
Wecare Strain Number
Bifidobacterium breveBBr*0.
Description
Bifidobacteriumbreve administered in
combination with prebiotics or other probiotics and standard
therapy has showed some beneficial effect. It is a constituent in
the therapeutic, nutritional treatment and is used to treat
ulcerative colitis. Appearance White to light yellow-colored,
free-flowing powder. Potency
- **0 billion CFU/g;
- Overage provided.
Morphology It is a gram-positive, catalase-negative, short
rod-shaped bacterium. Finished formats
- Depending on the final product design,
dosage, and dosage form, the product can be positioned according to
market needs and target group, such as bulk powder blends, bulk
finished capsules, chewable tablets, stick packs and other
formulations;
- Available upon request.
Excipients Select from one of the following:
- Maltodextrin; Inulin; Potato/Wheat/Maize starch;
- FOS; XOS; GOS; Stachyose; Polydextrose;
- Microcrystalline cellulose (processing aid);
- Silicon dioxide (processing aid);
- Magnesium stearate (processing aid);
Others available upon
request.
Applications
- Capsules, Powder, Tablets;
- Bars, Powdered Beverages. Storage Recommend storage at
refrigeration (4
℃) or frozen temperature
(**8
℃) in
original, sealed package until processed. Shelf Life Shelf life of
finished products is dependent upon excipient, processing and
storage conditions. Handling Bring powder to room temperature in
original package before use. Packaging material Product is packaged
in multi-layer, ultra-high barrier foil film which is heat-sealed.
Package sizes
- 1kg and 5kg;
- Availability can vary depending on product.
Shipping
- Shipping available worldwide;
-
Probiotic packages are typically transported in insulated styrofoam
shippers with ice packs to avoid exposure to extreme high
temperatures during transit.
Support documentation
Strain Identification Report.
